About Gerresheimer
Gerresheimer is a company based in Dusseldorf (Germany) founded in 1864 by Ferdinand Heye was acquired by Blackstone in November 2014. The company has 12,140 employees as of November 30, 2024. Gerresheimer has completed 4 acquisitions, including Blitzluxco, Bormioli Pharma and Sensile Medical. Gerresheimer offers products and services including Primary Packaging and Drug Delivery Systems.
- Headquarter Dusseldorf, Germany
- Employees 12140 as on 30 Nov, 2024
- Founders Ferdinand Heye
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gerresheimer Ag
-
Annual Revenue
$2.12 B (USD)2.28as on Nov 30, 2024
-
Net Profit
$113.99 M (USD)-5.52as on Nov 30, 2024
-
EBITDA
$414.21 M (USD)0.62as on Nov 30, 2024
-
Latest Funding Round
$603.85 M (USD), Debt – Conventional
Oct 08, 2019
- Investors
-
Employee Count
12140
as on Nov 30, 2024
-
Investments & Acquisitions
Blitzluxco
& 3 more
-
Acquired by
Blackstone
(Nov 11, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Gerresheimer
Gerresheimer is a publicly listed company on the XETR with ticker symbol GXI in Germany, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Gerresheimer
Gerresheimer offers a comprehensive portfolio of products and services, including Primary Packaging and Drug Delivery Systems.
High-quality glass and plastic packaging solutions are developed for pharmaceuticals and are utilized in various formulations.
Integrated solutions are provided from concept development to finished products for drug delivery, encompassing injectors and inhalers.
Funding Insights of Gerresheimer
Investors in Gerresheimer
Gerresheimer has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Blackstone.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management is provided across multiple asset classes.
|
Locked | Locked | Locked |
Investor details for Gerresheimer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gerresheimer
Gerresheimer has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Blitzluxco, Bormioli Pharma and Sensile Medical.
Investment portfolio details for Gerresheimer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug Delivery Solutions
|
Locked | Locked | 2004 | Locked | |
|
Manufacturer of technical plastics molding products
|
Locked | Locked | 1955 | Locked | |
|
Pharmaceutical packaging products are manufactured and supplied globally.
|
Locked | Locked | 1825 | Locked |
Complete acquisition details for Gerresheimer
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Gerresheimer
Detailed financials for Gerresheimer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gerresheimer Comparisons
Peer comparison for Gerresheimer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gerresheimer
Detailed competitors of Gerresheimer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gerresheimer
Complete news archive for Gerresheimer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gerresheimer
Gerresheimer was founded in 1864 and raised its 1st funding round 151 years after it was founded.
Gerresheimer is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
Dietmar Siemssen is the current CEO of Gerresheimer.
As of Nov 30, 2024, the latest employee count at Gerresheimer is 12,140.
Annual revenue of Gerresheimer is $2.12B as on Nov 30, 2024.
Gerresheimer was founded in 1864 in Dusseldorf, Germany, by Ferdinand Heye. Operations focus on the pharmaceutical, health, well-being, and biotech sectors. Glass and plastic packaging solutions are produced for drug delivery systems. Prefillable syringes and cartridges made of glass or plastic are offered as key products. The company serves global markets from its base in Germany.
Gerresheimer offers Primary Packaging and Drug Delivery Systems.
Yes, Gerresheimer is publicly traded on XETR under the ticker symbol GXI.
Gerresheimer has made 4 acquisitions, including Blitzluxco, Bormioli Pharma, and Sensile Medical.
Gerresheimer has 1 investor. Key investors include Blackstone.
The ticker symbol of Gerresheimer is GXI on XETR.